CDKN2B and lung carcinoma: Studies have shown that PPM1D and GADD45B may regulate the progress of LUAD through the p53 signaling pathway [32], and that down-regulation of CDKN2B-AS1 and CDKN2A may activate the p53 signaling pathway to promote lung cancer formation [33].